Stock Report

Atul Ltd Reports Strong Performance in Q1 FY27: Consolidated Net Profit Jumps 91.8% YoY to ₹253.93 Crore Driven by Chemical Segments

Posted On : 2026-07-24 17:55:46( TIMEZONE : IST )

Chemicals giant Atul Ltd (BSE: 531000, NSE: ATUL) announced its consolidated unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27). Backed by robust performance in its core chemical operations, the company registered strong double-digit growth in operational revenue and almost doubled its net profit on a year-on-year (YoY) basis.

Consolidated Financial Highlights: Q1 FY27 vs Q1 FY26

Revenue from Operations: Consolidated revenue from operations for the quarter stood at ₹1,847.95 crore, reflecting a 25.03% YoY increase compared to ₹1,478.00 crore reported in Q1 FY26. Sequentially, top-line revenue grew by 10.65% over ₹1,670.07 crore achieved in Q4 FY26.

Total Income: Expanded by 25.06% YoY to ₹1,881.26 crore for Q1 FY27, up from ₹1,504.24 crore in the corresponding period of the previous fiscal. Total income in Q4 FY26 was ₹1,759.64 crore.

Profit Before Tax (PBT): Climbed 95.92% YoY to ₹346.83 crore in Q1 FY27, compared to ₹177.03 crore in Q1 FY26. Sequentially, PBT gained 20.13% over ₹288.71 crore in Q4 FY26. This figure includes ₹2.09 crore as the share of net profit from associate and joint venture entities.

Net Profit (PAT): Net profit for the period surged by 91.85% YoY to ₹253.93 crore, up from ₹132.36 crore in Q1 FY26. On a sequential basis, profit after tax expanded by 20.28% from ₹211.12 crore reported in Q4 FY26.

Profit Attributable to Owners: Profit attributable to owners of the company came in at ₹245.30 crore, while non-controlling interests accounted for ₹8.63 crore.

Earnings Per Share (EPS): Basic and diluted EPS for the quarter reached ₹83.32 per share (face value ₹10/- each), up significantly from ₹43.40 in Q1 FY26 and ₹71.38 in Q4 FY26.

Total Comprehensive Income: Reached ₹375.41 crore in Q1 FY27 (with ₹366.77 crore attributable to owners), supported by ₹121.48 crore in other comprehensive income net of tax.

Segment-Wise Performance Overview

The Performance and Other Chemicals segment led the operational expansion during the quarter, showing remarkable margin improvement:

Performance and Other Chemicals

Segment Revenue: Reached ₹1,427.44 crore in Q1 FY27, marking a 33.79% YoY increase from ₹1,066.93 crore in Q1 FY26, and a sequential increase from ₹1,241.30 crore in Q4 FY26.

Segment Results: Soared 139.83% YoY to ₹239.83 crore, compared to ₹100.00 crore in Q1 FY26 and ₹124.94 crore in Q4 FY26.

Life Science Chemicals

Segment Revenue: Rose to ₹469.23 crore in Q1 FY27, compared to ₹449.20 crore in Q1 FY26 and ₹461.74 crore in Q4 FY26.

Segment Results: Stood at ₹92.78 crore, up 35.62% YoY from ₹68.41 crore in Q1 FY26, though lower than ₹143.06 crore recorded in Q4 FY26.

Others & Inter-Segment Reconciliations

Other Revenue: Contributed ₹25.98 crore (versus ₹16.36 crore in Q1 FY26), yielding segment results of ₹6.77 crore.

Inter-Segment Revenue: Stood at ₹74.70 crore, leaving sub-total segment revenue at ₹1,922.65 crore before inter-segment eliminations.

Cost Structure Analysis

Consolidated total expenses for Q1 FY27 stood at ₹1,536.52 crore, up 15.61% YoY from ₹1,329.08 crore in Q1 FY26:

Cost of Materials Consumed: Increased to ₹1,103.00 crore, compared to ₹791.09 crore in Q1 FY26 and ₹889.13 crore in Q4 FY26.

Purchases of Stock-in-Trade: Totaled ₹31.89 crore during the quarter.

Changes in Inventories: Resulted in an absorption of -₹187.77 crore, compared to -₹52.07 crore in Q1 FY26.

Power, Fuel, and Water: Remained flat YoY at ₹183.58 crore (versus ₹183.22 crore in Q1 FY26).

Employee Benefit Expenses: Stood at ₹132.18 crore, compared to ₹120.02 crore in Q1 FY26.

Depreciation & Amortisation: Amounted to ₹78.09 crore.

Finance Costs: Reduced slightly to ₹4.02 crore from ₹4.54 crore in Q1 FY26.

Other Expenses: Totaled ₹191.53 crore, compared to ₹180.67 crore in Q1 FY26.

Tax Provision: Total tax expense for the quarter was ₹92.90 crore (comprising ₹75.66 crore in current tax and ₹16.63 crore in deferred tax).

Standalone vs Consolidated Snapshot

On a standalone basis, Atul Ltd generated operational revenue of ₹1,588.60 crore in Q1 FY27 (up 21.77% YoY from ₹1,304.56 crore in Q1 FY26). Standalone Profit Before Tax came in at ₹269.85 crore (versus ₹134.51 crore in Q1 FY26), while Standalone Net Profit reached ₹201.03 crore (up 105.68% YoY from ₹97.74 crore in Q1 FY26). Basic and diluted standalone EPS stood at ₹68.28.

Segment Assets & Capital Allocation

As of June 30, 2026, total consolidated assets expanded to ₹8,528.42 crore, up from ₹7,503.43 crore in Q1 FY26 and ₹7,900.49 crore as of March 31, 2026.

Performance and Other Chemicals: Segment assets reached ₹4,166.73 crore (with liabilities at ₹1,069.91 crore).

Life Science Chemicals: Segment assets stood at ₹1,424.53 crore (with liabilities at ₹345.72 crore).

Unallocable Assets: Accounted for ₹2,685.47 crore, while unallocable liabilities stood at ₹418.92 crore. Total consolidated liabilities were reported at ₹1,856.49 crore, and paid-up equity share capital remained unchanged at ₹29.44 crore (face value ₹10/- per share).

Shares of Atul Limited was last trading in BSE at Rs. 6133.25 as compared to the previous close of Rs. 6139.75. The total number of shares traded during the day was 3908 in over 680 trades.

The stock hit an intraday high of Rs. 6325.00 and intraday low of 6110.00. The net turnover during the day was Rs. 24336063.00.